MICHAEL RAAB Insider Trading Transactions

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for MICHAEL RAAB.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of MICHAEL RAAB. MICHAEL RAAB is Director in AMICUS THERAPEUTICS INC ($FOLD) and President & CEO in ARDELYX, INC. ($ARDX).

Latest Insider Trading Transactions of MICHAEL RAAB

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, FOLD, ARDX

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Feb 24 2021ARDXARDELYX, INC.RAAB MICHAELPresident & CEOSellS6.882,53417,440217,288219.8 K to 217.3 K (-1.15 %)
Feb 24 2021ARDXARDELYX, INC.RAAB MICHAELPresident & CEOSellS6.882,53417,440217,288219.8 K to 217.3 K (-1.15 %)
Jan 07 2021ARDXARDELYX, INC.RAAB MICHAELPresident & CEOOption ExerciseA6.35517,9593,289,040517,959
Jan 07 2021ARDXARDELYX, INC.RAAB MICHAELPresident & CEOGrantA0.00115,1020219,822104.7 K to 219.8 K (+109.91 %)
Sep 17 2020ARDXARDELYX, INC.RAAB MICHAELPresident & CEOSellS5.61106,337596,285104,720211.1 K to 104.7 K (-50.38 %)
Jul 06 2020ARDXARDELYX, INC.RAAB MICHAELPresident & CEOSellS7.0123,128162,13024,36447.5 K to 24.4 K (-48.70 %)
Jul 06 2020ARDXARDELYX, INC.RAAB MICHAELPresident & CEOSellS7.0123,128162,13024,36447.5 K to 24.4 K (-48.70 %)
Jun 12 2020ARDXARDELYX, INC.RAAB MICHAELPresident & CEOBuyJ0.001,235047,49246.3 K to 47.5 K (+2.67 %)
Jun 08 2020FOLDAMICUS THERAPEUTIC ...RAAB MICHAELDirectorOption ExerciseA12.8118,574237,93318,574
Jun 08 2020FOLDAMICUS THERAPEUTIC ...RAAB MICHAELDirectorGrantA0.005,855021,00015.1 K to 21 K (+38.66 %)
Jun 03 2020FOLDAMICUS THERAPEUTIC ...RAAB MICHAELDirectorOption ExerciseM2.815,00014,0500
Jun 03 2020FOLDAMICUS THERAPEUTIC ...RAAB MICHAELDirectorSellS12.655,00063,26115,14520.1 K to 15.1 K (-24.82 %)
Jun 03 2020FOLDAMICUS THERAPEUTIC ...RAAB MICHAELDirectorBuyM2.815,00014,05020,14515.1 K to 20.1 K (+33.01 %)
Jun 02 2020ARDXARDELYX, INC.RAAB MICHAELPresident & CEOSellS7.3323,128169,63546,25769.4 K to 46.3 K (-33.33 %)
May 05 2020ARDXARDELYX, INC.RAAB MICHAELPresident & CEOSellS7.034,48631,53669,38573.9 K to 69.4 K (-6.07 %)
May 05 2020ARDXARDELYX, INC.RAAB MICHAELPresident & CEOSellS7.0115,941111,68673,87189.8 K to 73.9 K (-17.75 %)
Apr 17 2020ARDXARDELYX, INC.RAAB MICHAELPresident & CEOSellS7.029,42866,16989,81299.2 K to 89.8 K (-9.50 %)
Apr 17 2020ARDXARDELYX, INC.RAAB MICHAELPresident & CEOSellS7.0110,50073,64299,240109.7 K to 99.2 K (-9.57 %)
Apr 17 2020ARDXARDELYX, INC.RAAB MICHAELPresident & CEOSellS7.035003,515109,740110.2 K to 109.7 K (-0.45 %)
Mar 04 2020ARDXARDELYX, INC.RAAB MICHAELPresident & CEOOption ExerciseM1.0811,12312,0130
Mar 04 2020ARDXARDELYX, INC.RAAB MICHAELPresident & CEOSellS7.0120,428143,284110,240130.7 K to 110.2 K (-15.63 %)
Mar 04 2020ARDXARDELYX, INC.RAAB MICHAELPresident & CEOSellS7.0011,12377,861208,057219.2 K to 208.1 K (-5.07 %)
Mar 04 2020ARDXARDELYX, INC.RAAB MICHAELPresident & CEOBuyM1.0811,12312,013219,180208.1 K to 219.2 K (+5.35 %)
Feb 07 2020ARDXARDELYX, INC.RAAB MICHAELPresident & CEOOption ExerciseM1.0825,00027,00011,123
Feb 07 2020ARDXARDELYX, INC.RAAB MICHAELPresident & CEOSellS7.3225,000182,928206,828231.8 K to 206.8 K (-10.78 %)
Feb 07 2020ARDXARDELYX, INC.RAAB MICHAELPresident & CEOBuyM1.0825,00027,000231,828206.8 K to 231.8 K (+12.09 %)
Jan 13 2020ARDXARDELYX, INC.RAAB MICHAELPresident & CEOOption ExerciseA7.60557,4604,236,696557,460
Jul 01 2019FOLDAMICUS THERAPEUTIC ...RAAB MICHAELDirectorOption ExerciseA12.0019,473233,67619,473
Jul 01 2019FOLDAMICUS THERAPEUTIC ...RAAB MICHAELDirectorGrantA0.006,250015,1458.9 K to 15.1 K (+70.26 %)
Jun 06 2019ARDXARDELYX, INC.RAAB MICHAELPresident & CEOSellS2.5410,05425,551254,355264.4 K to 254.4 K (-3.80 %)
Jun 04 2019FOLDAMICUS THERAPEUTIC ...RAAB MICHAELDirectorOption ExerciseM7.155,00035,7500
Jun 04 2019FOLDAMICUS THERAPEUTIC ...RAAB MICHAELDirectorSellS11.165,00055,7768,89513.9 K to 8.9 K (-35.98 %)
Jun 04 2019FOLDAMICUS THERAPEUTIC ...RAAB MICHAELDirectorBuyM7.155,00035,75013,8958.9 K to 13.9 K (+56.21 %)
Jan 22 2019ARDXARDELYX, INC.RAAB MICHAELPresident & CEOOption ExerciseA2.32455,0001,055,600455,000
Jan 04 2019ARDXARDELYX, INC.RAAB MICHAELPresident & CEOSellS1.7019,64433,418261,409281.1 K to 261.4 K (-6.99 %)
Nov 15 2018ARDXARDELYX, INC.RAAB MICHAELPresident & CEOSellS2.846,53918,571292,499299 K to 292.5 K (-2.19 %)
Jul 30 2018ARDXARDELYX, INC.RAAB MICHAELPresident & CEOOption ExerciseA4.30185,000795,500185,000
Jul 30 2018ARDXARDELYX, INC.RAAB MICHAELPresident & CEOGrantA0.00200,0000299,03899 K to 299 K (+201.94 %)
Jun 11 2018FOLDAMICUS THERAPEUTIC ...RAAB MICHAELDirectorOption ExerciseA16.238,912144,6428,912
Jun 11 2018FOLDAMICUS THERAPEUTIC ...RAAB MICHAELDirectorGrantA0.003,08108,8955.8 K to 8.9 K (+52.99 %)
Apr 18 2018FOLDAMICUS THERAPEUTIC ...RAAB MICHAELDirectorOption ExerciseM10.535,00052,6500
Apr 18 2018FOLDAMICUS THERAPEUTIC ...RAAB MICHAELDirectorSellS14.415,00072,0585,81410.8 K to 5.8 K (-46.24 %)
Apr 18 2018FOLDAMICUS THERAPEUTIC ...RAAB MICHAELDirectorBuyM10.535,00052,65010,8145.8 K to 10.8 K (+86.00 %)
Jan 18 2018ARDXARDELYX, INC.RAAB MICHAELPresident & CEOOption ExerciseA7.10390,3482,771,471390,348
Jan 04 2018FOLDAMICUS THERAPEUTIC ...RAAB MICHAELDirectorOption ExerciseM7.514,36632,7895,634
Jan 04 2018FOLDAMICUS THERAPEUTIC ...RAAB MICHAELDirectorOption ExerciseM2.815,00014,0505,000
Jan 04 2018FOLDAMICUS THERAPEUTIC ...RAAB MICHAELDirectorSellS15.009,366140,4905,81415.2 K to 5.8 K (-61.70 %)
Jan 04 2018FOLDAMICUS THERAPEUTIC ...RAAB MICHAELDirectorBuyM15.009,366140,49015,1805.8 K to 15.2 K (+161.09 %)
Oct 16 2017FOLDAMICUS THERAPEUTIC ...RAAB MICHAELDirectorOption ExerciseM7.155,00035,7505,000
Oct 16 2017FOLDAMICUS THERAPEUTIC ...RAAB MICHAELDirectorOption ExerciseM10.535,00052,6505,000
Oct 16 2017FOLDAMICUS THERAPEUTIC ...RAAB MICHAELDirectorSellS14.2510,000142,5345,81415.8 K to 5.8 K (-63.24 %)
Oct 16 2017FOLDAMICUS THERAPEUTIC ...RAAB MICHAELDirectorBuyM14.2510,000142,53415,8145.8 K to 15.8 K (+172.00 %)
Aug 11 2017ARDXARDELYX, INC.RAAB MICHAELPresident & CEOOption ExerciseA4.7079,535373,81579,535
Aug 11 2017ARDXARDELYX, INC.RAAB MICHAELPresident & CEOGrantA0.0079,535099,03819.5 K to 99 K (+407.81 %)
Jun 15 2017FOLDAMICUS THERAPEUTIC ...RAAB MICHAELDirectorOption ExerciseA8.6016,236139,63016,236
Jun 15 2017FOLDAMICUS THERAPEUTIC ...RAAB MICHAELDirectorGrantA0.005,81405,8140 to 5.8 K
Jan 23 2017ARDXARDELYX, INC.RAAB MICHAELPresident & CEOOption ExerciseA13.90318,1414,422,160318,141
Jan 23 2017ARDXARDELYX, INC.RAAB MICHAELPresident & CEOGrantA0.0017,985019,5031.5 K to 19.5 K (+1,184.78 %)
Jun 13 2016FOLDAMICUS THERAPEUTIC ...RAAB MICHAELDirectorOption ExerciseA6.7120,000134,20020,000
Jan 20 2016ARDXARDELYX, INC.RAAB MICHAELPresident & CEOOption ExerciseA10.55301,2583,178,272301,258
Sep 10 2015ARDXARDELYX, INC.RAAB MICHAELPresident & CEOSellS20.299,785198,54470,38580.2 K to 70.4 K (-12.21 %)
Aug 27 2015ARDXARDELYX, INC.RAAB MICHAELPresident & CEOSellS20.001,10422,08080,17081.3 K to 80.2 K (-1.36 %)
Aug 04 2015ARDXARDELYX, INC.RAAB MICHAELPresident & CEOSellS20.003006,00081,24781.5 K to 81.2 K (-0.37 %)
Jul 30 2015ARDXARDELYX, INC.RAAB MICHAELPresident & CEOSellS20.002,11142,22081,54783.7 K to 81.5 K (-2.52 %)
Jun 12 2015FOLDAMICUS THERAPEUTIC ...RAAB MICHAELDirectorOption ExerciseA13.0920,000261,80020,000
Jun 09 2015FOLDAMICUS THERAPEUTIC ...RAAB MICHAELDirectorSellD12.658,936113,04008.9 K to 0 (-100.00 %)
Mar 12 2015ARDXARDELYX, INC.RAAB MICHAELPresident & CEOBuyJ0.00270270 to 27

Page:   1

Contact us | Follow us on Twitter